Texas Doctor Claims He Discovered Effective and Inexpensive Solution for COVID-19

AHA Publisher — Fri, 17 Jul 2020 07:00:10 +0000

Sara Middleton via NaturalHealth365 – Could a common drug called Budesonide really offer an effective, safe, and affordable COVID solution for ill patients? The answer may shock you, especially if you’ve been listening to the dire reports put out by the mainstream media. The truth is: a Texan emergency room doctor – with nearly 30 years of experience – has some very good news for those people concerned about COVID-19. And, thankfully, he’s currently working hard to get his message out about this potentially lifesaving steroid, no matter how reluctant some government officials may be to admit its promising impact. Medical Doctor Is Putting the Proverbial Fire of COVID-19 Out with Budesonide Budesonide is typically inhaled via a nebulizer, a non-invasive medical device that transforms medication into vapor so it can be breathed in by the patient through a handheld nozzle or simple face mask. The drug is commonly used to treat asthma. Because it helps alleviate inflammation in the body, doctors also use budesonide for other reasons, including managing symptoms of Crohn’s disease and ulcerative colitis. But, according to Texas ER physician Dr. Richard Bartlett, budesonide is helping his COVID patients recover extremely quickly and without the side effects commonly seen with other heavier-duty steroid medications. In a July 2 interview on the news show American Can We Talk, Dr. Bartlett explains: “My silver bullet is inhaled [generic] budesonide. It’s super cheap … with insurance, many of my patients are not even having to pay for it.” He continues: “[Budeosnide] is a respiratory anti-inflammatory for COVID – which is a respiratory inflammatory disease – and it works.” Dr. Bartlett has had a 100% success rate with this promising COVID treatment, and notes that many of his patients have reported feeling significantly better after just one five minute nebulizer treatment. In his clinical practice setting, he’s been treating very ill patients since March. See for yourself by watching this wonderful interview with Dr. Bartlett – below: In another interview shared by MSN, Dr. Bartlett says his COVID treatment plan for ill patients – many of whom are high risk due to underlying medical conditions and advanced age – is based on the complementary action of three main drugs: generic budesonide to fight inflammation and the so-called “cytokine storm” (a severe inflammatory process in the body often seen in COVID-19 that can lead to multi-organ failure and death), generic antibiotics to fight subsequent bacterial infections, and zinc, to interfere with replication of the novel coronavirus, SARS-CoV-2. “It’s common sense,” he adds bluntly. Dr. Bartlett has said that doctors in other countries including France and Spain are starting to explore the use of inhaled steroid medications for their COVID-19 patients. He also adds that the National Institutes of Health (NIH) will reportedly be looking into budesonide for use in the global pandemic, as well. We look forward to hearing more about budesonide and are curious to see whether it’ll start picking up more support in the media and scientific community. Sources for this article include: NewsWest9.com, Drugs.com, TexasHillCountry.com, MSN.com This article has been modified. To read the original article click here. For more articles from NaturalHealth365 click here.

The post Texas Doctor Claims He Discovered Effective and Inexpensive Solution for COVID-19 appeared first on Amazing Health Advances.

Skin Rash May Be a Symptom of COVID-19

AHA Publisher — Tue, 14 Jul 2020 07:00:30 +0000

Sally Robertson, B.Sc. via News-Medical Net – Researchers at King’s College London and Zoe Global Ltd have conducted a study suggesting that skin rashes could be valuable predictors of coronavirus disease 2019 (COVID-19). In a large community-based study, 8.8% of people who had tested positive for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) also reported having a skin rash. Among people who had not tested positive, but did report at least one classic symptom of COVID-19 symptom based on NHS guidelines, 8.2% also reported skin rashes. According to NHS guidelines, the three most common signs of COVID-19 are fever, persistent cough, and a reduced sense of smell (anosmia). Skin-related symptoms are not included, even though these can be easily spotted by patients, say Mario Falchi and team. The researchers say their findings strongly support including skin rashes, adding that although skin rashes are far less common than fever, they are much more specific and last longer. “Recognizing rashes is important in identifying new and earlier COVID-19 cases,” says the team. A pre-print version of the paper is available on the server medRxiv*, while the article undergoes peer review. The Link with Skin Manifestations Has Been Slow to Emerge It has become apparent during the COVID-19 pandemic that while the disease is primarily a respiratory illness, it also targets multiple organs, including the skin. Some studies have previously reported urticaria, chicken pox-like body rashes, and chilblains on the toes or fingers (acral rashes), possibly due to minor thrombotic events or damaged endothelium in small vessels of the digits. However, the link between COVID-19 and skin manifestations has been slower to emerge than it has for organs such as the heart, intestine, and brain. “COVID-19 rashes may present in many forms and at different stages of the disease. The heterogeneous presentations, the time delay, as well as the focus on severely ill patients during the early phases of the pandemic, led to the skin being overlooked as an important target organ for COVID-19,” say Falchi and colleagues. Now the researchers have used data available for 336,847 UK users of the COVID Symptom Study app to investigate the diagnostic value of skin rashes for infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The team also used data available for 11,546 people who participated in an independent survey on COVID-19-related skin symptoms. Skin Rashes Increased the Odds of SARS-CoV-2 Positivity More Than Fever Of 27,157 app users who provided swab test results, 2,021 (7.4%) were positive for SARS-CoV-2, and 25,136 (92.6%) were negative. Of the swab-positive individuals, 178 (8.8%) reported skin rashes (138 body rashes; 62 acral and 22 both body and acral), compared with 1357 (5.4%) of swab-negative individuals. Association analysis showed that the presence of body or acral rashes increased the likelihood of being swab positive for SARS-CoV-2 by 67%. This compares with fever increasing the odds of SARS-CoV-2 positivity by 47%, and fever is commonly used to screen for COVID, points out the team. Skin Rashes Were Also Predictive in Untested, But Symptomatic Users Among the 334,690 app users who did not provide a swab test result, 17,371 reported one of the three main symptoms (fever, persistent cough, and anosmia), which according to NHS guidelines, would require isolation and SARS-CoV-2 testing. Of those reporting one of the three typical symptoms, 8.2% also reported a skin rash, compared with 6% of untested users who did not report any of the three symptoms. Association analysis revealed that among untested users who reported one of the three main symptoms, the likelihood of having a body rash was 46% greater compared with those who did not report one of the symptoms. The increased likelihood of acral rash among those reporting a symptom was not statistically significant. The Findings Support the Inclusion of Skin Rashes as a Suspected Symptom To capture more information about the type, duration, and timing of rashes, the team analyzed data available for people 11,546 with a rash who participated in an independent survey on COVID-19-related skin symptoms. Among 694 responders who were positive for SARS-CoV-2 by swab or antibody test and provided information on COVID-19-related symptoms, the rash appeared before any other symptom in 17% of cases and in 21% of cases, the rash was the only symptom. “Twenty-one percent of the SARS-CoV-2 positive surveyees presented with skin symptoms alone and would have been missed if using the NHS classic symptoms alone,” write Falchi and colleagues. The researchers say the findings strongly support the inclusion of skin rashes as a suspected COVID-19 symptom. “Although, it is less prevalent than fever, it is more specific of COVID-19 and last longer,” they add. “An increased awareness from the public and healthcare professionals regarding COVID-19 skin changes will allow more efficient identification of new and earlier clusters of the disease,” concludes the team. *Important Notice medRxiv publishes preliminary scientific reports that are not peer-reviewed and, therefore, should not be regarded as conclusive, guide clinical practice/health-related behavior, or treated as established information. To read the original article click here.

The post Skin Rash May Be a Symptom of COVID-19 appeared first on Amazing Health Advances.

respirators Archives - Amazing Health Advances

Texas Doctor Claims He Discovered Effective and Inexpensive Solution for COVID-19

Skin Rash May Be a Symptom of COVID-19